Is There a Link Between Inflammation and Endocrinopathies in Turner Syndrome?
NCT ID: NCT05473091
Last Updated: 2023-10-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
179 participants
OBSERVATIONAL
2022-03-11
2022-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Associations of Age Measures With Serum Anti-Müllerian Hormone
NCT05297058
Metabolic Screening in Patients With Donnai-Barrow Syndrome
NCT01509287
Study of the Prevalence of Polymyositis and Dermatomyositis in Normandy
NCT02880527
The Association Between Autoimmune or Inflammation and Thyroid Disease
NCT02886949
Mechanisms Behind Development of Tendinopathy
NCT02797925
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
no intervention
retrospective analysis
Control group
no intervention
retrospective analysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
retrospective analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy subjects
18 Years
56 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
EVA FEIGERLOVA
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHUR de Nancy
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021pi189
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.